BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30786751)

  • 1. Modulation of Sympathetic Activity and Innervation With Chronic Ivabradine and β-Blocker Therapies: Analysis of Hypertensive Rats With Heart Failure.
    Kakehi K; Iwanaga Y; Watanabe H; Sonobe T; Akiyama T; Shimizu S; Yamamoto H; Miyazaki S
    J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):387-396. PubMed ID: 30786751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivabradine augments high-frequency dynamic gain of the heart rate response to low- and moderate-intensity vagal nerve stimulation under β-blockade.
    Kawada T; Yamamoto H; Uemura K; Hayama Y; Nishikawa T; Zheng C; Li M; Miyamoto T; Sugimachi M
    Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2201-H2210. PubMed ID: 33891515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal denervation mitigates cardiac remodeling and renal damage in Dahl rats: a comparison with β-receptor blockade.
    Watanabe H; Iwanaga Y; Miyaji Y; Yamamoto H; Miyazaki S
    Hypertens Res; 2016 Apr; 39(4):217-26. PubMed ID: 26631854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure.
    Morooka H; Iwanaga Y; Tamaki Y; Takase T; Akahoshi Y; Nakano Y; Fujiki H; Miyazaki S
    Circ Heart Fail; 2012 Jul; 5(4):484-92. PubMed ID: 22628529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible Ameliorative Effect of Ivabradine on the Autonomic and Left Ventricular Dysfunction Induced by Doxorubicin in Male Rats.
    El-Naggar AE; El-Gowilly SM; Sharabi FM
    J Cardiovasc Pharmacol; 2018 Jul; 72(1):22-31. PubMed ID: 29688913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquisition of brain Na sensitivity contributes to salt-induced sympathoexcitation and cardiac dysfunction in mice with pressure overload.
    Ito K; Hirooka Y; Sunagawa K
    Circ Res; 2009 Apr; 104(8):1004-11. PubMed ID: 19299647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of sympathetic activity and heart rate variability by ivabradine.
    Dias da Silva VJ; Tobaldini E; Rocchetti M; Wu MA; Malfatto G; Montano N; Zaza A
    Cardiovasc Res; 2015 Oct; 108(1):31-8. PubMed ID: 26101263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of heart rate reduction with ivabradine on vascular stiffness and endothelial function in chronic stable coronary artery disease.
    Hohneck AL; Fries P; Ströder J; Schneider G; Wagenpfeil S; Schirmer SH; Böhm M; Laufs U; Custodis F
    J Hypertens; 2019 May; 37(5):1023-1031. PubMed ID: 30672832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ivabradine prevents deleterious effects of dopamine therapy in heart failure: No role for HCN4 overexpression.
    Paterek A; Sochanowicz B; Oknińska M; Śmigielski W; Kruszewski M; Mackiewicz U; Mączewski M; Leszek P
    Biomed Pharmacother; 2021 Apr; 136():111250. PubMed ID: 33450487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivabradine improves quality of life in subjects with chronic heart failure compared to treatment with β-blockers: results of a multicentric observational APULIA study.
    Riccioni G; Masciocco L; Benvenuto A; Saracino P; De Viti D; Massari F; Meliota G; Buta F; Speziale G
    Pharmacology; 2013; 92(5-6):276-80. PubMed ID: 24296869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Chronic Heart Rate Reduction by I(f) Current Inhibitor Ivabradine on Left Ventricular Remodeling and Systolic Performance in Middle-Aged Rats With Postmyocardial Infarction Heart Failure.
    Dedkov EI; Bogatyryov Y; McCooey DS; Christensen LP; Weiss RM; Tomanek RJ
    J Cardiovasc Pharmacol Ther; 2015 May; 20(3):299-312. PubMed ID: 25287895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of cardiac sympathetic nerve innervation and excitability to cardiac hypertrophy in very elderly male hypertensive patients.
    Li S; Zhang L; Guo Y; Li X
    High Blood Press Cardiovasc Prev; 2013 Sep; 20(3):115-21. PubMed ID: 23918154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise.
    Joannides R; Moore N; Iacob M; Compagnon P; Lerebours G; Menard JF; Thuillez C
    Br J Clin Pharmacol; 2006 Feb; 61(2):127-37. PubMed ID: 16433867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
    Kobayashi M; Machida N; Mitsuishi M; Yamane Y
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remodelling of cardiac sympathetic re-innervation with thoracic spinal cord stimulation improves left ventricular function in a porcine model of heart failure.
    Liao SY; Liu Y; Zuo M; Zhang Y; Yue W; Au KW; Lai WH; Wu Y; Shuto C; Chen P; Siu CW; Schwartz PJ; Tse HF
    Europace; 2015 Dec; 17(12):1875-83. PubMed ID: 25767085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure.
    Esler M; Kaye D
    J Auton Nerv Syst; 1998 Oct; 72(2-3):210-9. PubMed ID: 9851571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Caloric Restriction Improves Cardiac Function, Remodeling, Adrenergic Responsiveness, and Sympathetic Innervation in a Model of Postischemic Heart Failure.
    de Lucia C; Gambino G; Petraglia L; Elia A; Komici K; Femminella GD; D'Amico ML; Formisano R; Borghetti G; Liccardo D; Nolano M; Houser SR; Leosco D; Ferrara N; Koch WJ; Rengo G
    Circ Heart Fail; 2018 Mar; 11(3):e004153. PubMed ID: 29535114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of testosterone upon cardiac sympathetic function in rats with induced heart failure.
    Han Y; Fu L; Sun W; Cao J; Xie R; Zhou P; Kang N; Sun J
    Eur J Pharmacol; 2009 Oct; 619(1-3):68-74. PubMed ID: 19665014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure.
    Floras JS
    J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):72A-84A. PubMed ID: 8376699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carotid Body Denervation Markedly Improves Survival in Rats With Hypertensive Heart Failure.
    Fujii K; Saku K; Kishi T; Oga Y; Tohyama T; Nishikawa T; Sakamoto T; Ikeda M; Ide T; Tsutsui H; Sunagawa K
    Am J Hypertens; 2017 Aug; 30(8):791-798. PubMed ID: 28430843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.